{
  "ticker": "CU6",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973223",
  "id": "02973223",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250728",
  "time": "0944",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m6fvg5z2khqn.pdf",
  "summary": "- **Capital Raising Announcement**:  \n  - **Structure**: Placement  \n  - **Total Securities Issued**: 48,485,212 ordinary shares (CU6)  \n  - **Issue Price**: AUD 4.20 per share  \n  - **Total Capital Raised**: ~AUD 203.6 million (48,485,212 \u00d7 4.20)  \n  - **Use of Proceeds**: Advance clinical portfolio and strengthen balance sheet  \n  - **Lead Manager**: Bell Potter Securities (5% management fee)  \n  - **Approval**: Utilizes 15% placement capacity (no shareholder approval required)  \n  - **Issue Date**: 28 July 2025  \n\nNo material timetable dates (ex-date, record date, close date) disclosed.",
  "usage": {
    "prompt_tokens": 1667,
    "completion_tokens": 161,
    "total_tokens": 1828,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-27T23:54:57.169365"
}